Rhythm Pharmaceuticals, Inc.
RYTM
$115.48
-$0.54-0.47%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -49.30M | -55.64M | -47.51M | -52.90M | -46.63M |
| Total Depreciation and Amortization | 251.00K | 252.00K | 272.00K | 304.00K | 379.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 29.24M | 28.21M | 22.54M | 22.87M | 18.42M |
| Change in Net Operating Assets | 10.65M | -17.01M | -691.00K | 3.11M | 4.53M |
| Cash from Operations | -9.15M | -44.19M | -25.39M | -26.62M | -23.31M |
| Capital Expenditure | -- | -- | -953.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 14.01M | 57.05M | 31.30M | -246.35M | 54.04M |
| Cash from Investing | 14.01M | 57.05M | 30.35M | -246.35M | 54.04M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 7.00M | 7.35M | 2.45M | 194.87M | 3.44M |
| Repurchase of Common Stock | -1.26M | -8.46M | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -6.91M | -4.29M | -5.40M | -5.57M | -4.33M |
| Cash from Financing | -1.17M | -5.40M | -2.95M | 189.30M | -889.00K |
| Foreign Exchange rate Adjustments | -217.00K | 448.00K | 64.00K | 304.00K | -279.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.48M | 7.92M | 2.07M | -83.36M | 29.55M |